54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 09
16:58 UTC
|
ABVX
Abivax
|
◎ Target | Allison Bratzel ★★★☆☆ #1260 | Overweight | $165.00→ $175.00+6.1% |
|
Jul 09
15:58 UTC
|
XPO
XPO
|
◎ Target | Ariel Rosa ★★☆☆☆ #2802 | Neutral | $236.00→ $226.00-4.2% |
|
Jul 09
15:58 UTC
|
WTW
Willis Towers Watson Public
|
◎ Target | Ryan Tunis ★★★☆☆ #1420 | Neutral | $322.00→ $344.00+6.8% |
|
Jul 09
15:58 UTC
|
UDR
United Dominion Realty Trust
|
◎ Target | Nicholas Yulico ★★★☆☆ #1423 | Sec→ r Perform | $38.00→ $41.00+7.9% |
|
Jul 09
15:58 UTC
|
TRV
Travelers Companies
|
◎ Target | Ryan Tunis ★★★☆☆ #1420 | Overweight | $335.00→ $360.00+7.5% |
|
Jul 09
15:58 UTC
|
SUPN
Supernus Pharmaceuticals
|
◎ Target | Kristen Kluska ★★★☆☆ #1695 | Overweight | $63.00→ $67.00+6.3% |
|
Jul 09
15:58 UTC
|
SRPT
Sarepta Therapeutics
|
◎ Target | Biren Amin ★★☆☆☆ #2869 | Neutral | $23.00→ $20.00-13.0% |
|
Jul 09
15:58 UTC
|
RYAN
Ryan Specialty
|
◎ Target | Ryan Tunis ★★★☆☆ #1420 | Neutral | $33.00→ $34.00+3.0% |
|
Jul 09
15:58 UTC
|
RNR
RenaissanceRe
|
◎ Target | Ryan Tunis ★★★☆☆ #1420 | Overweight | $340.00→ $354.00+4.1% |
|
Jul 09
15:58 UTC
|
REGN
Regeneron Pharmaceuticals
|
◎ Target | Biren Amin ★★☆☆☆ #2869 | Overweight | $855.00→ $854.00-0.1% |
|
Jul 09
15:58 UTC
|
MTZ
MasTec
|
◎ Target | Manish A. Somaiya not yet tracked | Overweight | $545.00→ $581.00+6.6% |
|
Jul 09
15:58 UTC
|
MRSH
Marsh & McLennan Companies
|
◎ Target | Ryan Tunis ★★★☆☆ #1420 | Overweight | $210.00→ $218.00+3.8% |
|
Jul 09
15:58 UTC
|
MAA
Mid-America Apartment Communities
|
◎ Target | Nicholas Yulico ★★★☆☆ #1423 | Sec→ r Underperform | $129.00→ $137.00+6.2% |
|
Jul 09
15:58 UTC
|
ESS
Essex Property Trust
|
◎ Target | Nicholas Yulico ★★★☆☆ #1423 | Sec→ r Outperform | $290.00→ $307.00+5.9% |
|
Jul 09
15:58 UTC
|
EQR
Equity Residential
|
◎ Target | Nicholas Yulico ★★★☆☆ #1423 | Sec→ r Perform | $67.00→ $70.00+4.5% |
|
Jul 09
15:58 UTC
|
EG
Everest Group
|
◎ Target | Ryan Tunis ★★★☆☆ #1420 | Neutral | $344.00→ $390.00+13.4% |
|
Jul 09
15:58 UTC
|
CPT
Camden Property Trust
|
◎ Target | Nicholas Yulico ★★★☆☆ #1423 | Sec→ r Underperform | $102.00→ $109.00+6.9% |
|
Jul 09
15:58 UTC
|
CI
Cigna Group
|
◎ Target | Lance Wilkes ★★☆☆☆ #2898 | Outperform | $371.00→ $381.00+2.7% |
|
Jul 09
15:58 UTC
|
CB
Chubb
|
◎ Target | Ryan Tunis ★★★☆☆ #1420 | Neutral | $318.00→ $337.00+6.0% |
|
Jul 09
15:58 UTC
|
BRX
Brixmor Property Group
|
◎ Target | Michael Goldsmith ★★★★☆ #716 | Buy | $34.00→ $37.00+8.8% |
|
Jul 09
15:58 UTC
|
AVB
AvalonBay Communities
|
◎ Target | Nicholas Yulico ★★★☆☆ #1423 | Sec→ r Perform | $187.00→ $195.00+4.3% |
|
Jul 09
15:58 UTC
|
AON
AON
|
◎ Target | Ryan Tunis ★★★☆☆ #1420 | Overweight | $416.00→ $445.00+7.0% |
|
Jul 09
15:58 UTC
|
ALL
Allstate
|
◎ Target | Ryan Tunis ★★★☆☆ #1420 | Neutral | $236.00→ $242.00+2.5% |
|
Jul 09
15:58 UTC
|
AJG
Arthur J. Gallagher & Co.
|
◎ Target | Ryan Tunis ★★★☆☆ #1420 | Neutral | $285.00→ $300.00+5.3% |
|
Jul 09
15:58 UTC
|
TECH
Bio-Techne
|
↓ Downgrade | Dan Leonard ★★★★☆ #712 | Outperform→ Sector Perform | $62.00→ $73.00+17.7% |
|
Jul 09
15:58 UTC
|
FIVE
Five Below
|
↓ Downgrade | firm only | Sec→ r Perform | |
|
Jul 09
15:58 UTC
|
DCO
Ducommun
|
↓ Downgrade | Ken Herbert not yet tracked | Outperform→ Sector Perform | $155.00→ $175.00+12.9% |
|
Jul 09
15:58 UTC
|
AVAV
AeroVironment
|
↓ Downgrade | Ken Herbert not yet tracked | Outperform→ Sector Perform | $210.00→ $180.00-14.3% |
|
Jul 09
15:58 UTC
|
FIVE
Five Below
|
↑ Upgrade | Spencer Hanus ★★★★☆ #478 | Cautious→ Outperform | |
|
Jul 09
14:57 UTC
|
XEL
Xcel Energy
|
◎ Target | Nicholas Campanella ★★★★☆ #926 | Overweight | $87.00→ $90.00+3.4% |
|
Jul 09
14:57 UTC
|
WYNN
Wynn Resorts
|
◎ Target | Brandt Montour ★★★☆☆ #2188 | Overweight | $139.00→ $134.00-3.6% |
|
Jul 09
14:57 UTC
|
TPG
TPG
|
◎ Target | Devin Ryan ★★★★☆ #657 | Market Outperform | $75.00→ $68.00-9.3% |
|
Jul 09
14:57 UTC
|
STEP
StepStone Group
|
◎ Target | Benjamin Budish ★★☆☆☆ #2448 | Overweight | $62.00→ $60.00-3.2% |
|
Jul 09
14:57 UTC
|
SRE
Sempra Energy
|
◎ Target | Nicholas Campanella ★★★★☆ #926 | Overweight | $105.00→ $103.00-1.9% |
|
Jul 09
14:57 UTC
|
SCHW
Charles Schwab
|
◎ Target | Benjamin Budish ★★☆☆☆ #2448 | Overweight | $127.00→ $122.00-3.9% |
|
Jul 09
14:57 UTC
|
SBET
Sharplink Gaming
|
◎ Target | Devin Ryan ★★★★☆ #657 | Market Outperform | $30.00 |
|
Jul 09
14:57 UTC
|
SAR
Saratoga Investment
|
◎ Target | Sean-Paul Adams ★★★★★ #39 | Neutral | $23.00→ $22.00-4.3% |
|
Jul 09
14:57 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Michael Schmidt ★★★☆☆ #2255 | Buy | $205.00→ $235.00+14.6% |
|
Jul 09
14:57 UTC
|
RRR
Red Rock Resorts
|
◎ Target | Brandt Montour ★★★☆☆ #2188 | Overweight | $65.00→ $72.00+10.8% |
|
Jul 09
14:57 UTC
|
RJF
Raymond James Financial
|
◎ Target | Devin Ryan ★★★★☆ #657 | Market Outperform | $190.00→ $200.00+5.3% |
|
Jul 09
14:57 UTC
|
RJF
Raymond James Financial
|
◎ Target | Benjamin Budish ★★☆☆☆ #2448 | Overweight | $182.00→ $192.00+5.5% |
|
Jul 09
14:57 UTC
|
PSX
Phillips 66
|
◎ Target | Theresa Chen ★★☆☆☆ #2370 | Equal Weight | $177.00→ $183.00+3.4% |
|
Jul 09
14:57 UTC
|
PENN
PENN Entertainment
|
◎ Target | Felicia Hendrix not yet tracked | Overweight | $24.00→ $26.00+8.3% |
|
Jul 09
14:57 UTC
|
PENG
Penguin Solutions
|
◎ Target | Tom O'Malley not yet tracked | Equal Weight | $27.00→ $40.00+48.1% |
|
Jul 09
14:57 UTC
|
PD
PagerDuty
|
◎ Target | Joel Fishbein not yet tracked | Buy | $9.00→ $11.00+22.2% |
|
Jul 09
14:57 UTC
|
OWL
Blue Owl Capital
|
◎ Target | Brian McKenna ★★★★★ #143 | Market Outperform | $21.00→ $17.00-19.0% |
|
Jul 09
14:57 UTC
|
NOW
ServiceNow
|
◎ Target | Miller Jump ★★☆☆☆ #2337 | Buy | $120.00→ $130.00+8.3% |
|
Jul 09
14:57 UTC
|
NDAQ
Nasdaq
|
◎ Target | Benjamin Budish ★★☆☆☆ #2448 | Overweight | $114.00→ $108.00-5.3% |
|
Jul 09
14:57 UTC
|
MTZ
MasTec
|
◎ Target | Justin Hauke ★★☆☆☆ #2700 | Outperform | $473.00→ $475.00+0.4% |
|
Jul 09
14:57 UTC
|
MRX
Marex Group plc Ordinary Shares
|
◎ Target | Benjamin Budish ★★☆☆☆ #2448 | Overweight | $60.00→ $76.00+26.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.